Skip to content

Establishment and application of the technology system about capture of circular epithelial cells in peripheral blood, target gene expression and single cell sequencing

Establishment and application of the technology system about capture of circular epithelial cells in peripheral blood, target gene expression and single cell sequencing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024505
Enrollment
Unknown
Registered
2019-07-13
Start date
2019-07-20
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal congenital heart disease

Interventions

Gold Standard:echocardiography or Amniocentesis
Index test:The&#32
test&#32
results&#32
of&#32

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant woman; 2. The pregnant age 11-28 weeks and is calculated by last menstruation; 3. A single birth is determined by Prenatal diagnosis; 4. The fetus has heart abnormalities evaluated by ultrasound.

Exclusion criteria

Exclusion criteria: 1. Non-pregnant woman; 2. The pregnant age is 1-10 weeks or more than 28 weeks; 3. Twins or multiple births.

Design outcomes

Primary

MeasureTime frame
fetal cells;

Countries

China

Contacts

Public ContactBo Han

Shandong Provincial Hospital

hanbo35@163.com+86 13605313927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026